DH News and Press, Definitive Healthcare Corp. From 10/18/21

Life sciences companies can perform rapid, iterative analysis on medical and prescription claims data to develop customized reports that accelerate go-to-market activities Definitive Healthcare (Nasdaq: DH ), an industry leader in healthcare commercial intelligen...

Gainers: Protagonist Therapeutics (NASDAQ:PTGX) +82%, Adamas Pharmaceuticals (NASDAQ:ADMS) +74%, Flexion Therapeutics (NASDAQ:FLXN) +62%, Evelo Biosciences (NASDAQ:EVLO) +16%, Progenity (NASDAQ:PROG) +16%. Losers: Voyager Therapeutics (NASDAQ:VYGR)...

Definitive Healthcare has seen a very successful public offering as investors like the role which it plays in a complex healthcare system. I like the role and prospects of the company and while it has good traction on the commercial side, valuations are far too high to be involved her...

Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced the closing of its previously announced initial public offering of 17,888,888 shares of its Class A common stock, which includes th...

The IPO market was full steam ahead this past week as 11 IPOs came to market. SPAC activity remained steady with seven blank check IPOs. New filers continue to pour into the IPO pipeline, with 15 IPOs and eight SPACs submitting initial filings. For further details see: U...